ORIOn-E: A Study Evaluating CPI-1205 in Patients With Advanced Solid Tumors

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

December 14, 2017

Primary Completion Date

June 12, 2019

Study Completion Date

June 12, 2019

Conditions

Advanced Solid Tumors

Interventions

DRUG

CPI-1205

Administered orally

DRUG

ipilimumab

Administered intravenously

Trial Locations (3)

START Midwest, Grand Rapids

The University of Texas - MD Anderson Cancer Center, Houston

South Texas Oncology & Hematology, San Antonio